期刊文献+

Roles of sulfonylurea receptor 1 and multidrug resistance protein 1 in modulating insulin secretion in human insulinoma 被引量:1

Roles of sulfonylurea receptor 1 and multidrug resistance protein 1 in modulating insulin secretion in human insulinoma
下载PDF
导出
摘要 BACKGROUND:Sulfonylurea receptor 1(SUR1)and multidrug resistance protein 1(MRP1)are two prominent members of multidrug resistance proteins associated with insulin secretion. The aims of this study were to investigate their expression in insulinomas and their sole and synergistic effects in modulating abnormal insulin secretion. METHODS:Fasting glucose,insulin and C-peptide were measured in 11 insulinoma patients and 11 healthy controls. Prolonged oral glucose tolerance tests were performed in 6 insulinoma patients.Insulin content,SUR1 and MRP1 were detected in 11 insulinoma patients by immunohistochemistry. SUR1 and MRP1 were also detected in 6 insulinoma patients by immunofluorescence. RESULTS:Insulinoma patients presented the typical demons-trations of Whipple’s triad.Fasting glucose of each insulinoma patient was lower than 2.8 mmol/L,and simultaneous insulin and C-peptide were increased in insulinoma patients. Prolonged oral glucose tolerance tests showed that insulin secretion in insulinoma patients were also stimulated by high glucose.Immunohistochemistry and immunofluorescence staining showed that SUR1 increased,but MRP1 decreased in insulinoma compared with the adjacent islets. CONCLUSIONS:The hypersecretion of insulin in insulinomas might be,at least partially,due to the enrichment of SUR1. In contrast,MRP1,which is down-regulated in insulinomas, might reflect a negative feedback in insulin secretion. BACKGROUND:Sulfonylurea receptor 1(SUR1)and multidrug resistance protein 1(MRP1)are two prominent members of multidrug resistance proteins associated with insulin secretion. The aims of this study were to investigate their expression in insulinomas and their sole and synergistic effects in modulating abnormal insulin secretion. METHODS:Fasting glucose,insulin and C-peptide were measured in 11 insulinoma patients and 11 healthy controls. Prolonged oral glucose tolerance tests were performed in 6 insulinoma patients.Insulin content,SUR1 and MRP1 were detected in 11 insulinoma patients by immunohistochemistry. SUR1 and MRP1 were also detected in 6 insulinoma patients by immunofluorescence. RESULTS:Insulinoma patients presented the typical demons-trations of Whipple's triad.Fasting glucose of each insulinoma patient was lower than 2.8 mmol/L,and simultaneous insulin and C-peptide were increased in insulinoma patients. Prolonged oral glucose tolerance tests showed that insulin secretion in insulinoma patients were also stimulated by high glucose.Immunohistochemistry and immunofluorescence staining showed that SUR1 increased,but MRP1 decreased in insulinoma compared with the adjacent islets. CONCLUSIONS:The hypersecretion of insulin in insulinomas might be,at least partially,due to the enrichment of SUR1. In contrast,MRP1,which is down-regulated in insulinomas, might reflect a negative feedback in insulin secretion.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2011年第1期88-94,共7页 国际肝胆胰疾病杂志(英文版)
关键词 sulfonylurea receptor 1 multidrug resistance protein 1 ATP-binding cassette transporters INSULINOMA insulin secretion sulfonylurea receptor 1 multidrug resistance protein 1 ATP-binding cassette transporters insulinoma insulin secretion
  • 相关文献

参考文献38

  • 1D. A. Chistiakov,V. A. Potapov,D. C. Khodirev,M. S. Shamkhalova,M. V. Shestakova,V. V. Nosikov.Genetic variations in the pancreatic ATP-sensitive potassium channel, β-cell dysfunction, and susceptibility to type 2 diabetes[J]. Acta Diabetologica . 2009 (1)
  • 2Guettier JM,Gorden P.Insulin secretion and insulin-producing tumors. Expert Rev Endocrinol Metab . 2010
  • 3Gussinyer M,Clemente M,Cebrián R,Yeste D,Albisu M,Carrascosa A.Glucose intolerance and diabetes are observed in the long-term follow-up of nonpancreatectomized patients with persistent hyperinsulinemic hypoglycemia of infancy due to mutations in the ABCC8gene. Diabetes Care . 2008
  • 4Sempoux C,Guiot Y,Dahan K,Moulin P,Stevens M,Lambot V,et al.The focal form of persistent hyperinsulinemic hypoglycemia of infancy:morphological and molecular studies show structural and functional differences with insulinoma. Diabetes . 2003
  • 5Bellanné-Chantelot C,Saint-Martin C,Ribeiro MJ,Vaury C,Verkarre V,Arnoux JB,et al.ABCC8and KCNJ11molecular spectrum of109patients with diazoxide-unresponsive congenital hyperinsulinism. Journal of Medical Genetics . 2010
  • 6Shimomura K,de Nanclares GP,Foutinou C,Caimari M,Castaro L,Ashcroft FM.The first clinical case of a mutation at residue K185of Kir6.2(KCNJ11):a major ATP-binding residue. Diabetic Medicine . 2010
  • 7Sandal T,Laborie LB,Brusgaard K,Eide SA,Christesen HB,S?vik O,et al.The spectrum of ABCC8mutations in Norwegian patients with congenital hyperinsulinism of infancy. Clinical Genetics . 2009
  • 8Smith AJ,Partridge CJ,Asipu A,Mair LA,Hunter M,Sivaprasadarao A.Increased ATP-sensitive K+channel expression during acute glucose deprivation. Biochemical and Biophysical Research Communications . 2006
  • 9Miki T,Nagashima K,Seino S.The structure and function of the ATP-sensitive K+channel in insulin-secreting pancreatic beta-cells. Journal of Molecular Endocrinology . 1999
  • 10Cohen MM Jr.Persistent hyperinsulinemic hypoglycemia of infancy. American Journal of Medical Genetics . 2003

二级参考文献1

共引文献10

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部